Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer

BACKGROUND: Patients with curable esophageal cancer (EC) who proceed beyond the original Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) eligibility criteria are also treated with neoadjuvant chemoradiotherapy (nCRT). This study assessed the effect that extending the CROSS...

Descripción completa

Detalles Bibliográficos
Autores principales: de Heer, E. C., Hulshoff, J. B., Klerk, D., Burgerhof, J. G. M., de Groot, D. J. A., Plukker, J. Th. M., Hospers, G. A. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486922/
https://www.ncbi.nlm.nih.gov/pubmed/28188501
http://dx.doi.org/10.1245/s10434-017-5797-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486922/
https://www.ncbi.nlm.nih.gov/pubmed/28188501
http://dx.doi.org/10.1245/s10434-017-5797-3

Ejemplares similares